Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/1995
07/11/1995US5432178 Amidinophenol derivatives
07/11/1995US5431924 Anti-inflammatory composition derived from emu oil
07/11/1995US5431902 New medicament aerosol formulation based on fusafungine
07/06/1995WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
07/06/1995WO1995018131A1 New ginkgolide derivatives and a process for preparing them
07/06/1995WO1995018129A1 Diazabicyclic neurokinin antagonists
07/06/1995WO1995018124A1 Substituted morpholine derivatives and their use as therapeutic agents
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995WO1995017891A1 2,3-diaryl-1-benzopyrans for treating dermatitis
07/06/1995WO1995017888A1 Phenylmethyl hexanamides, and the use thereof
07/06/1995WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2589968A1 The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture
07/06/1995CA2180177A1 2,3-diaryl-1-benzopyrans for treating dermatitis
07/06/1995CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
07/06/1995CA2177736A1 New ginkgolide derivatives and a process for preparing them
07/05/1995EP0661055A1 Pharmaceutical formulation containing clobetasone and tobramycin and applications thereof
07/05/1995EP0661036A1 Antiacne composition for the simultaneous treatment of superficial and lower layers of the skin
07/05/1995EP0660825A1 Anti-inflammatory macrolactam (cyclamenol)
07/05/1995EP0660708A1 Phospholipids
07/05/1995CN1104497A Triglycerides
07/05/1995CN1104492A Anti-inflammatory analgesic plaster
07/05/1995CN1029230C Method for preparing of hydroxamic acid and N-hydroxyurea derivatives
07/04/1995US5430067 Dihydroanthraquinonecarboxylic acids
07/04/1995US5430051 Photodynamic diagnosis and therapy of rheumatic diseases
07/04/1995US5430050 Hispidospermidin
07/04/1995US5430032 Treating asthma, allergy, inflammation
07/04/1995CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives
07/04/1995CA1336177C Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus
06/1995
06/29/1995WO1995017399A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
06/29/1995WO1995017392A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
06/29/1995WO1995017389A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995WO1995017388A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995WO1995017382A1 Non-peptide tachykinin receptor antagonists
06/29/1995WO1995017379A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
06/29/1995WO1995017182A1 Protein kinase c inhibitors
06/29/1995WO1995017181A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/29/1995WO1995017095A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/29/1995WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
06/29/1995CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma.
06/29/1995CA2178833A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
06/29/1995CA2178209A1 Anellated dihydropyridines and the use thereof for preparing pharmaceutical preparations
06/29/1995CA2178088A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995CA2176130A1 Non-peptide tachykinin receptor antagonists
06/29/1995CA2176127A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/29/1995CA2155098A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/28/1995EP0659080A1 Method and composition for the treatment of hair loss
06/28/1995EP0456720B1 High ibuprofen content granulations
06/27/1995US5428181 Treatment of bone disorders, osteoporosis
06/27/1995US5428051 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
06/27/1995US5428044 Anti-inflammatory 4-aminophenyl derivatives
06/27/1995US5428040 Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
06/27/1995US5428038 Benzopyranones, a method for producing them and uses therefor
06/27/1995US5428033 Saturated hydroxyalkylquinoline acids as leukotriene antagonists
06/27/1995US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
06/27/1995US5427919 Hydrolytic enzyme inhibitors/inactivators and methods for using same
06/27/1995CA2060333C Use of pyrimido-benzothiazine derivatives
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/22/1995WO1995016702A1 Peptide inhibitors of cxc intercrine molecules
06/22/1995WO1995016687A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995WO1995016679A1 Morpholine and thiomorpholine tachykinin receptor antagonists
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016443A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995WO1995016353A1 Systemic gene treatment of connective tissue diseases
06/22/1995WO1995013380A3 Method and reagent for treatment of arthritic conditions
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995CA2179009A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176247A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995CA2155929A1 Systemic gene treatment of connective tissue diseases
06/22/1995CA2138513A1 Methods of inhibiting myeloperoxidase activity
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/22/1995CA2135979A1 Biaryl phospholipase a2 inhibitors
06/21/1995EP0658559A1 Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
06/21/1995EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof
06/21/1995EP0658347A2 Pharmaceutical composition, containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin
06/21/1995EP0658115A1 Peptide medicaments for treating disease
06/21/1995EP0552292B1 Substituted imidazobenzazepines and imidazopyridoazepines
06/20/1995US5426197 Antiinflammatory, antiallergy or antitumor agents
06/20/1995US5426044 Minactivin compositions and antibodies to minactivin
06/16/1995CA2137739A1 Polycyclic aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their use
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015961A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995WO1995015959A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015956A1 Bicyclic carboxylic acid leukotriene b4 antagonists
06/15/1995WO1995015953A1 Novel substituted oxazolidines
06/15/1995WO1995015950A1 Compounds
06/15/1995WO1995015949A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015939A1 Tricyclic derivatives, pharmaceutical compositions containing them
06/15/1995WO1995015752A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2178634A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups